Prof. Dr. med. Benjamin Meder
Deputy Medical Director (Clinic for Cardiology, Angiology, Pneumology)
Head (Institute for Cardiomyopathies Heidelberg)
Lead (cardiac catheter)
Group leader (AG Molecular Genetic Laboratory for Functional Molecular Genetics and Translational Biotechnology
Prof. Dr. Benjamin Meder is a cardiomyopathy specialist and interventional cardiologist and has a long track-record in experimental and translational research. He is the Deputy Medical Director of the Center for Cardiology, Angiology and Pulmonology of the University Hospital Heidelberg and group leader for Molecular Genetics and Translational Biotechnology.
He is head of the Institute for Cardiomyopathies Heidelberg (ICH.), which is a precision medicine unit dedicated to heart muscle disorders. In the ICH. outpatient unit more than 2000 patients per year are diagnosed and treated according to state-of-the-art methods. As first center world-wide the team introduced next-gen sequencing technologies in the assessment of cardiomyopathy patients and commercialized their first assay in 2010.
As incoming speaker of the working group for cardiomyopathies of the German Society of Cardiology he envisages to harmonize treatment pathways and quality of care for cardiomyopathy patients, which is supported by a national registry on cardiomyopathies within the German Center for Cardiovascular Research (DZHK-TORCH-Plus).
He has published numerous high-ranked studies on genetic cardiomyopathies and is involved in several large-scale national and international networks on this topic. Since 2018, he is visiting Assoc. Prof. of Genetics at Stanford University, one of the world's leading universities, to conduct research in the fields of precision medicine and advanced genetic technologies. Using his background in technology, he has strongly embarked on computational sciences and artificial intelligence in the newly founded Informatics for Life consortium to propel the translation of novel concepts towards more efficient treatments of patients.
